Evolution Advisers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$1K – 64
2026
Q2
$1K Buy
+5
New +$1.08K ﹤0.01% 171
2025
Q1
– Sell
-8
Closed -$1K – 152
2024
Q4
$1K Hold
8
– – ﹤0.01% 148
2024
Q3
$1K Hold
8
– – ﹤0.01% 155
2024
Q2
$1K Buy
+8
New +$1.32K ﹤0.01% 147

Other funds holding ABBV

Evolution Advisers's ABBV Position: Q3 2026 in Review

Evolution Advisers sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 5 shares — an estimated $1K sold.

Evolution Advisers first reported a position in ABBV in Q2 2024 and held it in 4 quarters. The position peaked at $1K in Q2 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Evolution Advisers reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Evolution Advisers sold 5 AbbVie shares in Q3 2026, an estimated $1K.
  • Evolution Advisers first reported a position in AbbVie in Q2 2024 and held it in 4 quarters.
  • Evolution Advisers's AbbVie position peaked at $1K in Q2 2026.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Evolution Advisers's 13F filing for Q3 2026, filed 6 Nov 2026.